Effusions

  • Rudolf C. Ulirsch
  • Dena M. Gomez
Part of the Cancer Growth and Progression book series (CAGP, volume 7)

Abstract

Effusions may develop in any of the serous membrane-lined body cavities. The peritoneal, pleural, and pericardial spaces are the principal mesothelial-lined body cavities that cause clinical diagnostic problems. All three major body cavities share the characteristic that they are normally more accurately described as potential spaces. When fluid of any type develops in this “potential space”, it separates the layers of the body cavity. Excessive accumulation of fluid may result in compromise of normal organ functions. In this respect, the heart is particularly subject to the effects of fluid accumulation in the pericardial sac. Compromise of ventricular filling in diastole may result in cardiac tamponade and rapid death. In the pleural cavities, fluid accumulation will lead to respiratory compromise by preventing normal lung expansion. Fluid accumulation is perhaps best tolerated in the peritoneal cavity, but eventually this also results in discomfort, respiratory compromise, and difficulty with mobility.

Keywords

Pleural Effusion Pericardial Effusion Mesothelial Cell Ascitic Fluid Pleural Fluid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Adegbite AB, Khan M: Role of protein content in CSF ascites following ventriculoperitoneal shunting. Case Report. J Neurosurg 57: 423, 1982PubMedCrossRefGoogle Scholar
  2. 2.
    Agha FP, Amendola MA, Shirazi KK et al.: Unusual abdominal complications of ventriculo-peritoneal shunts. Radiology 146: 323, 1983PubMedGoogle Scholar
  3. 3.
    Almagro UA, Remeniuk E: Non-Hodgkin’s lymphoma presenting as a malignant pericardial effusion and cardiac tamponade. Hum Pathol 16: 315, 1985PubMedCrossRefGoogle Scholar
  4. 4.
    Appelqvist P, Silvo J, Salmela L, Kostiainen S: On the treatment and prognosis of malignant ascites: Is the survival time determined when the abdominal paracentesis is needed? J Surg Oncol 20: 238, 1982PubMedCrossRefGoogle Scholar
  5. 5.
    Askin FB, McCann BG, Kuhn C: Reactive eosinophilic pleuritis: A lesion to be distinguished from pulmonary eosinophilic granuloma. Arch Pathol Lab Med 101: 187, 1977PubMedGoogle Scholar
  6. 6.
    Bakalos D, Constantakis N, Tsicricas TH: Recognition of malignant cells in pleural and peritoneal effusions. Acta Cytol 18: 118, 1974PubMedGoogle Scholar
  7. 7.
    Barton JC, Durant JR: Isolated chylopericardium associated with lymphoma. South Med J 73: 1551, 1980PubMedCrossRefGoogle Scholar
  8. 8.
    Battifora H, Trowbridge IS: A monoclonal antibody useful for the differential diagnosis between malignant lymphoma and non-hematopoietic neoplasms. Cancer 51:816, 1983PubMedCrossRefGoogle Scholar
  9. 9.
    Bauer TW, Erozan YS: Psammoma bodies in small cell carcinoma of the lung: A case report. Acta Cytol 26: 327, 1982PubMedGoogle Scholar
  10. 10.
    Bauman MD, Borowitz MJ, Johnston WW: Immunocytologic evaluation of lymphoid aspirates and effusions (Abstract). Acta Cytol 28: 628, 1984Google Scholar
  11. 11.
    Becklake MR: Exposure to asbestos and human disease (editorial). N Engl J Med 306: 1480, 1982PubMedCrossRefGoogle Scholar
  12. 12.
    Bell RC, Andrews CP: Pleural effusions: Meeting the diagnostic challenge. Geriatrics 40: 101, 1985PubMedGoogle Scholar
  13. 13.
    Bennett RR, Moore J Jr: Dialysis-induced ascites treated with peritoneal dialysis. South Med J 80: 379, 1987PubMedCrossRefGoogle Scholar
  14. 14.
    Bessone LN, Ferguson TB, Burford TH: Chylothorax. Ann Thorac Surg 12: 527, 1971PubMedCrossRefGoogle Scholar
  15. 15.
    Bewtra C, Greer KP: Ultrastructural studies of cells in body cavity effusions. Acta Cytol 29: 226, 1985PubMedGoogle Scholar
  16. 16.
    Biran S, Brufman G, Klein E, Hochman A: The management of pericardial effusion in cancer patients. Chest 71: 182, 1977PubMedCrossRefGoogle Scholar
  17. 17.
    Blot WJ, Harrington JM, Toledo A et al.: Lung cancer after employment in shipyards during World War II. N Engl J Med 299: 620, 1978PubMedCrossRefGoogle Scholar
  18. 18.
    Bollum FJ: Terminal deoxynucleotidyl transferase as a hematopoietic cell marker. Blood 54: 1203, 1979PubMedGoogle Scholar
  19. 19.
    Bonnet P, Smadja C, Szekely AM et al.: Intractable ascites in systemic mastocytosis treated by portal diversion. Dig Dis Sci 32: 209, 1987PubMedCrossRefGoogle Scholar
  20. 20.
    Bramwell ME, Ghosh AK, Smith WD et al.: Ca2 and Ca3: New monoclonal antibodies evaluated as tumor markers in serous effusions. Cancer 56: 105, 1985PubMedCrossRefGoogle Scholar
  21. 21.
    Britt DA, Schumann GB: Frequency of malignant body cavity effusion cytology (Abstract). Acta Cytol 28: 637, 1984Google Scholar
  22. 22.
    Britt K, Kaneko M, Chuang MT: Hemangioleiomyosarcoma of the pleura: A case report and review of the literature. Mt Sinai J Med (NY) 50: 64, 1983Google Scholar
  23. 23.
    Broghamer WL Jr, Richardson ME, Faurest SE: Malignancy-associated serosanguinous pleural effusions. Acta Cytol 28: 46, 1984PubMedGoogle Scholar
  24. 24.
    Buhaug J, Rone R, Ramzy I: Presentation of squamous-cell carcinoma in effusions (Abstract). Acta Cytol 27: 567, 1983Google Scholar
  25. 25.
    Calabrese PR, Frank HD, Taubin HL: Lymphangiomyomatosis with chylous ascites: Treatment with dietary fat restriction and medium chain triglycerides. Cancer 40: 895, 1977PubMedCrossRefGoogle Scholar
  26. 26.
    Cardoza PL: A critical evaluation of 3000 cytologic analyses of pleural fluid, ascitic fluid, and pericardial fluid. Acta Cytol 10: 455, 1966Google Scholar
  27. 27.
    Carrington CB, Cugell DW, Gaensler EA et al.: Lymphangioleiomyomatosis: Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 116: 977, 1977PubMedGoogle Scholar
  28. 28.
    Chee YC, Chea A: IgA myeloma with primary pleural involvement. Eur J Respir Dis 65: 136, 1984PubMedGoogle Scholar
  29. 29.
    Chen KT: Extracardiac malignancy presenting with cardiac tamponade. J Surg Oncol 23: 167, 1983PubMedCrossRefGoogle Scholar
  30. 30.
    Cheson BD, Johnston JL, delJunco G, Kjeldsberg CR: Cytologic evidence for disseminated immunoblastic lymphoma. Am J Clin Pathol 75: 621, 1981PubMedGoogle Scholar
  31. 31.
    Cheung DK, Raaf JH: Selection of patients with malignant ascites for a peritoneovenous shunt. Cancer 50: 1204, 1982PubMedCrossRefGoogle Scholar
  32. 32.
    Churg A: Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol 9: 360, 1985PubMedCrossRefGoogle Scholar
  33. 33.
    Churg A: Lung cancer cell type and asbestos exposure. JAMA 253: 2984, 1985PubMedCrossRefGoogle Scholar
  34. 34.
    Churg A, Warnock ML, Green N: Analysis of the cores of ferruginous (asbestos) bodies from the general population II. True asbestos bodies and pseudoasbestos bodies. Lab Invest 40: 31, 1979PubMedGoogle Scholar
  35. 35.
    Coleman DV, To A, Dearnaley DP, Ormerod MG: An immunocytochemical approach to the cytodiagnosis of malignancy in serous effusions (Abstract). Acta Cytol 25: 716, 1981Google Scholar
  36. 36.
    Corrin B, Liebow AA, Friedman PJ: Pulmonary Lymphangiomyomatosis: A review. Am J Pathol 79: 347, 1975Google Scholar
  37. 37.
    Courant C, Brun G: [Mucoid peritonitis. Apropos of 2 case reports. Review of the literature]. Rev Fr Gynecol Obstet 79: 641, 1984PubMedGoogle Scholar
  38. 38.
    Craighead JE, Mossman BT: The pathogenesis of asbestos-associated diseases. N Eng J Med 306: 1446, 1982CrossRefGoogle Scholar
  39. 39.
    Czerniak B, Papenhausen PR, Herz F, Koss LG: Flow cytometric identification of cancer cells in effusions with Cal monoclonal antibody. Cancer 55: 2783, 1985PubMedCrossRefGoogle Scholar
  40. 40.
    Danova M, Riccardi A, Girino M et al.: Severe pericarditis as a presenting sign of bronchogenic carcinoma. Tumori 71: 81, 1985PubMedGoogle Scholar
  41. 41.
    Das DK, Gupta SK, Ayyagari S et al.: Pleural effusions in non-Hodgkin’s lymphoma. A cytomorphologic, cytochemical and immunologic study. Acta Cytol (Baltimore) 31: 119, 1987Google Scholar
  42. 42.
    D’Cruz IA, Sengupta EE, Abrahams C et al.: Cardiac involvement, including tuberculous pericardial effusion, complicating acquired immune deficiency syndrome. Am Heart J 112: 1100, 1986PubMedCrossRefGoogle Scholar
  43. 43.
    deHaan HP, Kolff J, Buis B: Isolated chylopericardium due to lymphangiomatous dysplasia of the thymus. Eur Heart J 5: 846, 1984Google Scholar
  44. 44.
    Desai SD, Sackett DL: Ratios of pleural fluid to serum immunoglobulins in malignant pleural effusions. Cancer 52: 2151, 1983PubMedCrossRefGoogle Scholar
  45. 45.
    Desitter L, Rector WG: The significance of bloody ascites in patients with cirrhosis. Am J Gastroenterol 79: 136, 1984PubMedGoogle Scholar
  46. 46.
    Dienemann H, Witte J, Szabo L: [Chylaskos in lymphangioleiomyomatosis. Peritoneo-venous drainage with Denver shunt]. Dtsch Med Wochenschr 7: 920, 1985CrossRefGoogle Scholar
  47. 47.
    Dixon AY, Reed JS, Dow N, Lee SH: Primary omental leiomyosarcoma masquerading as hemorrhagic ascites. Hum Pathol 15: 233, 1984PubMedCrossRefGoogle Scholar
  48. 48.
    Duane GB, Sanchez CA, Sugahara R et al.: Mesothelial cell transformation: Morphologic classification and biologic implications deduced from light and transmission electron microscopic investigation (Abstract). Acta Cytol 28: 658, 1984Google Scholar
  49. 49.
    Edwards MSB, Davis RL, Laurent JP: Tumor markers and cytologic features of cerebrospinal fluid. Cancer 56: 1773, 1985PubMedCrossRefGoogle Scholar
  50. 50.
    Elborn JS, Conn P, Roberts SD: Refractory massive pleural effusion in systemic lupus erythematosus treated by pleurectomy. Ann Rheum Dis 46: 77, 1987PubMedCrossRefGoogle Scholar
  51. 51.
    Enzi G, Digito M, Marin R et al.: Mediastino-abdominal lipomatosis: Deep accumulation of fat mimicking a respiratory disease and ascites. Clinical aspects and metabolic studies in vitro. Q J Med 53: 453, 1984Google Scholar
  52. 52.
    Epstein DM, Kline LR, Albedla SM, Miller WT: Tuberculous pleural effusions. Chest 91: 106, 1987PubMedCrossRefGoogle Scholar
  53. 53.
    Estrov Z, Berrebi A, Hazani E, Resnitzky P: Pleural effusion and ascites as presenting signs of IgA myeloma. Haematologica (Pavia) 68: 104, 1983Google Scholar
  54. 54.
    Evans DA, Thornthwaite JT, Ng ABP, Sugarbaker EV: DNA flow cytometry of pleural effusions: Comparison with pathology for the diagnosis of malignancy (Abstract). Acta Cytol25: 707, 1981Google Scholar
  55. 55.
    Falini B, Taylor C: New developments in immunoperoxidase techniques and their application. Arch Pathol Lab Med 107: 105, 1983PubMedGoogle Scholar
  56. 56.
    Farber HW, Fairman RP, Glauser FL: Talc granulomatosis: Laboratory findings similar to sarcoidosis. Am Rev Respir Dis 125: 258, 1982PubMedGoogle Scholar
  57. 57.
    Felding C, Christensen RF, Lindhal F: Ammonia tolerance test used to differentiate between ascites of cirrhotic and malignant genesis. Scand J Gastroenterol 19: 365, 1984PubMedGoogle Scholar
  58. 58.
    Fentiman IS, Rubens RD, Hayward JL: The pattern of metastatic disease in patients with pleural effusions secondary to breast cancer. Br J Surg 69: 193, 1982PubMedCrossRefGoogle Scholar
  59. 59.
    Flint A, Lovett EJ, Stoolman LM et al.: Flow cytometric analysis of DNA in diagnostic cytology. Am J Clin Pathol 84: 278, 1985PubMedGoogle Scholar
  60. 60.
    Fraser RS, Viloria JB, Wang NS: Cardiac tamponade as a presentation of extracardiac malignancy. Cancer 45: 1697, 1980PubMedCrossRefGoogle Scholar
  61. 61.
    Fukuoka M, Takada M, Tamai Set al.: [Local application of anti-cancer drugs for the treatment of malignant pleural and pericardial effusion]. Gan To Kagaku Ryoho 11: 1543, 1984PubMedGoogle Scholar
  62. 62.
    Funahashi A, Sarkar TK, Kory RC: Measurements of respiratory gases and pH of pleural fluid. Am Rev Respir Dis 108: 1266, 1973PubMedGoogle Scholar
  63. 63.
    Gagushin VA: [Method of treating ascites by draining into the subcutaneous compartment of the thigh]. Vestn Khir 132:122, 1984Google Scholar
  64. 64.
    Gallareto M, Ghiazza GF, DeGiogis L, Gabutto U: [Chromosome analysis performed in 176 cases of pleural effusions of various types]. Arch Sci Med (Torino) 139: 193, 1982Google Scholar
  65. 65.
    Gough IR: Control of malignant ascites by peritoneovenous shunting. Cancer 54: 2226, 1984PubMedCrossRefGoogle Scholar
  66. 66.
    Grobe JL, Kozarek RA, Sanowski RA, Earnest DL: “Pseudo-ascites” associated with giant ovarian cysts and elevated cystic fluid amylase. Am J Gastroenterol 78: 421, 1983PubMedGoogle Scholar
  67. 67.
    Hacker JF III, Richter JE, Pyatt RS, Fink MP: Hemorrhagic ascites: An unusual presentation of primary splenic lymphoma. Gastroenterology 83: 470, 1982PubMedGoogle Scholar
  68. 68.
    Halme J, Chafe W, Currie JL: Endometriosis with massive ascites. Obstet Gynecol 65: 591, 1985PubMedGoogle Scholar
  69. 69.
    Hedley DW, Philips J, Rugg CA, Taylor IW: Measurement of cellular DNA content as an adjunct to diagnostic cytology in malignant effusions. Eur J Cancer Clin Oncol 20: 749, 1984PubMedCrossRefGoogle Scholar
  70. 70.
    Hirji MK, Johnson MA, Hennig RC: Cardiac levorotation: A cause of false-positive epicardial fat pad sign. Radiology 161: 659, 1986PubMedGoogle Scholar
  71. 71.
    Hobar PC, Turner WW Jr, Vaentine RJ: Successful use of the Denver peritoneovenous shunt in patients with nephrogenic ascites. Surgery 101: 161, 1987PubMedGoogle Scholar
  72. 72.
    Horikoshi T, Hiyoshi Y, Ota M et al.: A child with acute lymphoblastic leukemia complicated by pericardial effusion. Nippon Ketsueki Gakkai Zasshi 49: 900, 1986PubMedGoogle Scholar
  73. 73.
    Houston MC: Pleural effusion: Diagnostic value of measurements of PO2, PCO2, and pH. South Med J 74: 585, 1981PubMedCrossRefGoogle Scholar
  74. 74.
    Hurvitz CH, Greenberg SH, Song CH, Gans SL: Hemangiomatosis of the pleura with hemorrhage and disseminated intravascular coagulation. J Pediatr Surg 17: 73, 1982PubMedCrossRefGoogle Scholar
  75. 75.
    Iuchi K, Sawamura K, Mori T et al.: [A case of non-Hodgkin’s lymphoma with pyothorax]. Nippon Kyobu Shikkan Gakkai Zasshi 22: 1165, 1984PubMedGoogle Scholar
  76. 76.
    Jaffe R, Di Segni E, Altaras M et al.: Ultrasonic real-time diagnosis of transitory fetal pleural and pericardial effusion. Diagn Imag Clin Med 55: 373, 1986Google Scholar
  77. 77.
    James LP: Cytopathology of lymphoid lesions in serous effusions (abstr). Acta Cytol 25: 715, 1981Google Scholar
  78. 78.
    Janckila AJ, Yam LT, Li CY: Immunocytochemical diagnosis of acute leukemia with pleural involvement. Acta Cytol 29: 67, 1985PubMedGoogle Scholar
  79. 79.
    Jenks JE, Artman LE, Hoskins WJ, Miremadi AK: Endometriosis with ascites. Obstet Gynecol 63 (Suppl 3): 75S, 1984PubMedGoogle Scholar
  80. 80.
    Johnston WW: The malignant pleural effusion: A review of cytopathologic diagnoses of 584 specimens from 472 consecutive patients. Cancer 56: 905, 1985PubMedCrossRefGoogle Scholar
  81. 81.
    Johnston WW, Szpak CA, Lottich SC et al.: Use of a monoclonal antibody (B72.3) as an immunocytochemical adjunct to diagnosis of adenocarcinoma in human effusions. Cancer Res 45: 1894, 1985PubMedGoogle Scholar
  82. 82.
    Kagan E, Jacobson RJ: Lymphoid and plasma cell malignancies: Asbestos-related disorders of long latency. Am J Clin Pathol 80: 14, 1983PubMedGoogle Scholar
  83. 83.
    Kapila K, Chopra P, Verma K: Cytologic diagnosis of amelanotic melanoma (Letter to the editor). Acta Cytol 29: 498, 1985PubMedGoogle Scholar
  84. 84.
    Keshgegian AA: Lupus erythematosus cells in pleural fluid (Letter to the editor). Am J Clin Pathol 69: 570, 1978PubMedGoogle Scholar
  85. 85.
    Kjeldsberg CR, Knight JA: Body fluids: Laboratory examination of cerebrospinal, synovial, and serous fluids: A textbook atlas. pp 28–47. Chicago: American Society of Clinical Pathologists, 1982Google Scholar
  86. 86.
    Klein AL, Baird MG, Walley V: Tumor encasement of the heart simulating pericardial effusion. Can J Cardiol 2: 341, 1986PubMedGoogle Scholar
  87. 87.
    Komp DM, Cox BJ: Cytocentrifugation in the management of central nervous system leukemia. J Pediatr 81: 992, 1972PubMedCrossRefGoogle Scholar
  88. 88.
    Koss LG: Diagnostic Cytology and its Histopathologic Bases, 3rd Ed, pp 878–970. Philadelphia: JB Lippincott Co., 1979Google Scholar
  89. 89.
    Kreisman H, Wolkove N, Finkelstein HS et al.: Breast cancer and thoracic metastases: Review of 119 patients. Thorax 38: 175, 1983PubMedCrossRefGoogle Scholar
  90. 90.
    Kruskall MS, Carter SR, Ritz LP: Contamination of cerebrospinal fluid by vertebral bone-marrow cells during lumbar puncture. N Engl J Med 308: 697, 1983PubMedCrossRefGoogle Scholar
  91. 91.
    Kubonishi I, Ohtsuki Y, Ken-Ichi M et al.: Granulocytic sarcoma presenting as a mediastinal tumor: Report of a case and cytological and cytochemical studies of tumor cells in vivo and in vitro. Am J Clin Pathol 82: 730, 1984Google Scholar
  92. 92.
    Kudsk K, Fabian TC, Minton JP: Leveen shunts in patients with intractable malignant ascites. J Surg Oncol 13: 61, 1980PubMedCrossRefGoogle Scholar
  93. 93.
    Kurtz RC, Bronzo RL: Does spontaneous bacterial peritonitis occur in malignant ascites? Am J Gastroenterol 77: 146, 1982PubMedGoogle Scholar
  94. 94.
    Kusaka H, Itabashi K, Suzuki J et al.: [A case of granulocytic sarcoma with near tetraploidy and pleural and pericardial effusions as initial manifestations]. Nippon Naika Gakkai Zasshi 73: 1170, 1984PubMedCrossRefGoogle Scholar
  95. 95.
    Kutty CPK, Remeniuk E, Varkey B: Malignant-appearing cells in pleural effusion due to pancreatitis: Case report and literature review. Acta Cytol 25: 412, 1981PubMedGoogle Scholar
  96. 96.
    Kutty CPK, Varkey B: Incidence and distribution of intrathoracic metastases from renal cell carcinoma. Arch Intern Med 144: 273, 1984PubMedCrossRefGoogle Scholar
  97. 97.
    Kyrkou KA, Iatridis SG, Athanassiadou PP et al.: Detection of benign or malignant origin of ascites with combined indirect immunoperoxidase assays of carcinoembryonic antigen and lysozyme. Acta Cytol 29: 57, 1985PubMedGoogle Scholar
  98. 98.
    Lacy JH, Wieman TJ, Shively EH: Management of malignant ascites. Surg Gynecol Obstet 159: 397, 1984PubMedGoogle Scholar
  99. 99.
    Levine RJ (ed): Asbestos: An Information Resource. DHEW Publication No. (NIH) 79–1681. National Cancer Institute, Bethesda, 1978Google Scholar
  100. 100.
    Light RW, Erozan YS, Ball WC: Cells in pleural fluid: Their value in differential diagnosis. Arch Intern Med 132: 854, 1973PubMedCrossRefGoogle Scholar
  101. 101.
    Light RW, Girard WM, Jenkinson SG, George RB: Para-pneumonic effusions. Am J Med 69: 507, 1980PubMedCrossRefGoogle Scholar
  102. 102.
    Light RW, MacGregor MI, Ball WC, Luchsinger PC: Diagnostic significance of pleural fluid pH and PCO2. Chest 64: 591, 1973PubMedCrossRefGoogle Scholar
  103. 103.
    Light RW, MacGregor MI, Luchsinger PC et al.: Pleural effusions: The diagnostic separation of transudates and exudates. Ann Intern Med 77: 507, 1972PubMedGoogle Scholar
  104. 104.
    Light RW, Moller DJ, George RB: Low pleural fluid pH in parapneumonic effusion (Letter to editor). Chest 68: 273, 1975PubMedCrossRefGoogle Scholar
  105. 105.
    Lirzin P, Zeitoun P, Vandromme L, Salas H: [Carcinoembryonic antigen in ascites and pleural effusions]. Gastroenterol Clin Biol 8: 222, 1984PubMedGoogle Scholar
  106. 106.
    Liss HP: Cope needle biopsy. South Med J 77: 837, 1984PubMedCrossRefGoogle Scholar
  107. 107.
    Lokich J, Reinhold R, Silverman M, Tullis J: Complications of peritoneovenous shunt for malignant ascites. Cancer Treat Rep 64: 305, 1980PubMedGoogle Scholar
  108. 108.
    López JM, Delgado JL, Tovar E, Gonzalez AG: Massive pericardial effusion produced by extracardiac malignant neoplasms. Arch Intern Med 143: 1815, 1983PubMedCrossRefGoogle Scholar
  109. 109.
    Lukes RJ, Collins RD: New approaches to the classification of the lymphomata. Br J Cancer 31: 1, 1975CrossRefGoogle Scholar
  110. 110.
    Marchevsky AM, Hauptman E, Gil J, Watson C: Computerized interactive morphometry as an aid in the diagnosis of pleural effusions. Acta Cytol (Baltimore) 31: 131, 1987Google Scholar
  111. 111.
    Martin SE, Zhang H, Magyarosy E et al.: Immunologic methods in cytology. Definitive diagnosis of non-Hodgkin’s lymphomas using immunologic markers for T- and B-cells. Am J Clin Pathol 82: 666, 1984PubMedGoogle Scholar
  112. 112.
    Martinez-Vea A, Gatell JM, Segura F et al.: Diagnostic value of tumoral markers in serous effusions: Carcinoembryonic antigen, alpha,-acid glycoprotein, alpha-fetoprotein, phosphohexose isomerase, and beta-2-microglobulin. Cancer 50: 1783, 1982PubMedCrossRefGoogle Scholar
  113. 113.
    McCaughey WTE, Dardick I, Barr JR: Angiosarcoma of serous membranes. Arch Pathol Lab Med 107: 304, 1983PubMedGoogle Scholar
  114. 114.
    McCaughey WTE, Kannerstein M, Churg J: Tumors and pseudotumors of the serous membranes: Atlas of Tumor Pathology, 2nd series, Fascicle 20. Washington DC: Armed Forces Institute of. Pathology, 1985Google Scholar
  115. 115.
    Melamed MR: The cytological presentation of malignant lymphomas and related diseases in effusions. Cancer 16: 413, 1963PubMedCrossRefGoogle Scholar
  116. 116.
    Ménard S, Rilke F, Torre GD et al.: Sensitivity enhancement of the cytologic detection of cancer cells in effusions by monoclonal antibodies. Am J Clin Pathol 83: 571, 1985PubMedGoogle Scholar
  117. 117.
    Morelj ND, Frost D, Ziel HK: Pseudo Meigs syndrome. A case report. J Reprod Med 25: 88, 1980Google Scholar
  118. 118.
    Mufti GJ, Oscier DG, Hamblin TJ et al.: Serous effusions in monocytic leukaemias. Br J Haematol 58: 547, 1984PubMedCrossRefGoogle Scholar
  119. 119.
    Mukai K: Malignant mesothelioma and CEA staining (Letter to the editor). Am J Surg Pathol 9: 159, 1985PubMedGoogle Scholar
  120. 120.
    Mulrow CD, Corey GR: Pericardial pseudoeffusion due to steroid-induced lipomatosis. NC Med J 46: 179, 1985Google Scholar
  121. 121.
    Mungall IP, Cowen PN, Cooke NT et al.: Multiple pleural biopsy with the Abrams needle. Thorax 35: 600, 1980PubMedCrossRefGoogle Scholar
  122. 122.
    Nadji M: The potential value of immunoperoxidase techniques in diagnostic cytology. Acta Cytol 24: 442, 1980PubMedGoogle Scholar
  123. 123.
    Nagasawa T, Nagasawa S: Enrichment of malignant cells from pleural effusions by Percoll density gradients. Acta Cytol27:119, 1983Google Scholar
  124. 124.
    Naib ZM: Exfoliative Cytopathology, 3rd edn, pp 349–380. Boston: Little, Brown and Co, 1985Google Scholar
  125. 125.
    Naraynsingh V, Raju GC, Ratan P, Wong J: Massive ascites due to omental endometriosis. Postgrad Med J 61: 539, 1985PubMedCrossRefGoogle Scholar
  126. 126.
    Naylor B: The exfoliative cytology of diffuse malignant mesothelioma. J Pathol Bact 86: 293, 1963CrossRefGoogle Scholar
  127. 127.
    Newman TG, Soni, A, Acaron S, Huang CT: Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest 91: 459, 1987PubMedCrossRefGoogle Scholar
  128. 128.
    Nissim F, Ashkenazy M, Borenstein R, Czernobilsky B: Tuberculoid cornstarch granulomas with caseous necrosis: A diagnostic challenge. Arch Pathol Lab Med 105: 86, 1981PubMedGoogle Scholar
  129. 129.
    Oosterlee J: Peritoneovenous shunting for ascites in cancer patients. Br J Surg 67: 663, 1980PubMedCrossRefGoogle Scholar
  130. 130.
    Orell SR, Dowling KD: Oncofetal antigens as tumor markers in the cytologic diagnosis of effusions. Acta Cytol 27: 625, 1983PubMedGoogle Scholar
  131. 131.
    Osamura RY, Shioya S, Handa K et al.: Lupus erythematosus cells in pleural fluid: Cytologic diagnosis in two patients. Acta Cytol 21: 215, 1977Google Scholar
  132. 132.
    Pandyna MH, Agus B, Grady RF: In vivo LE phenomenon in pleural fluid. Arthritis Rheum 19: 962, 1976CrossRefGoogle Scholar
  133. 133.
    Peterman TA, Speicher CE: Evaluating pleural effusions: A two-stage laboratory approach. JAMA 252: 1051, 1984PubMedCrossRefGoogle Scholar
  134. 134.
    Pinio MM: Electron microscopy of effusions (Abstract). Acta Cytol 27: 554, 1983Google Scholar
  135. 135.
    Piver MS, Lele SB, Patsner B: Pseudomyxoma peritonei: Possible prevention of mucinous ascites by peritoneal lavage. Obstet Gynecol 64: 95S, 1984Google Scholar
  136. 136.
    Poe RH, Israel RH, Utell MJ et al.: Sensitivity, specificity, and predictive values of closed pleural biopsy. Arch Intern Med 144: 325, 1984PubMedCrossRefGoogle Scholar
  137. 137.
    Poe RH, Qazi R, Israel RH et al.: Survival of patients with pleural involvement by breast carcinoma. Am J Clin Oncol 6: 523, 1983PubMedGoogle Scholar
  138. 138.
    Pomeranz SJ, Hawkins HH, Towbin R et al.: Granulocytic sarcoma (Chloroma): CT manifestations. Radiology 155: 167, 1985PubMedGoogle Scholar
  139. 139.
    Potts DE, Levin DC, Sahn SA: Pleural fluid pH in para-pneumonic effusions. Chest 70: 328, 1976PubMedCrossRefGoogle Scholar
  140. 140.
    Potts DE, Taryle DA, Sahn SA: The glucose-pH relationship in parapneumonic effusions. Arch Intern Med 138: 1378, 1978PubMedCrossRefGoogle Scholar
  141. 141.
    Potts DE, Willcox MA, Good JT et al.: The acidosis of low-glucose pleural effusions. Am Rev Respir Dis 117: 665, 1978PubMedGoogle Scholar
  142. 142.
    Prakash UBS, Reiman HM: Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: Analysis of 414 cases. Mayo Clin Proc 60: 158, 1985PubMedGoogle Scholar
  143. 143.
    Pugatch RD, Spirn PW: Radiology of the pleura. Clin Chest Med 6: 17, 1985PubMedGoogle Scholar
  144. 144.
    Ramaekers F, Haag D, Jap P, Vooijs PG: Immunochemical demonstration of keratin and vimentin in cytologic aspirates. Acta Cytol 28: 385, 1984PubMedGoogle Scholar
  145. 145.
    Reda MG, Baigelman W: Pleural effusions in systemic lupus erythematosus. Acta Cytol 24: 553, 1980PubMedGoogle Scholar
  146. 146.
    Reinhold RB, Lokich JJ, Tomashefski J, Costello P: Management of malignant ascites with peritoneovenous shunting. Am J Surg 145: 455, 1983PubMedCrossRefGoogle Scholar
  147. 147.
    Reisberg IR, Oyakawa S: Mastocytosis with malabsorption, myelofibrosis, and massive ascites. Am J Gastroenterol 82: 54, 1987PubMedGoogle Scholar
  148. 148.
    Rosai J: Ackerman’s Surgical Pathology, pp 494, 1487. The C.V. Mosby Co., St. Louis, 1981Google Scholar
  149. 149.
    Rosen SE, Vonderheid EC, Koprowska I: Mycosis fungoides with pulmonary involvement: Cytopathologic findings. Acta Cytol 28: 51. 1984PubMedGoogle Scholar
  150. 150.
    Rovensky YA, Gvichiya AS, Vasiliev JM: SEM study of the attachment of mouse ascitic hepatoma cells to various substrata. Scan Electron Microsc 3: 71, 1980PubMedGoogle Scholar
  151. 151.
    Safa AM, Van Orstrand HS: Pleural effusion due to myeloma. Chest 64: 246, 1973PubMedCrossRefGoogle Scholar
  152. 152.
    Sahn SA, Taryle DA, Good JT: Experimental empyema: Time course and pathogenesis of pleural fluid acidosis and low pleural fluid glucose. Am Rev Respir Dis 120: 355, 1979PubMedGoogle Scholar
  153. 153.
    Salhadin A, Nasiell M, Nasiell K et al.: The unique cytologic picture of oat cell carcinoma in effusions. Acta Cytol 20: 298, 1976PubMedGoogle Scholar
  154. 154.
    Sandenbergh HA, Woodruff JD: Histogenesis of pseudomyxoma peritonei. Review of 9 cases. Obstet Gynecol 49: 339, 1977PubMedGoogle Scholar
  155. 155.
    Schneller J, Eppich E, Greenbaum E et al.: Flow cytometry and feulgen cytophotometry in evaluation of effusions. Cancer 59: 1307, 1987PubMedCrossRefGoogle Scholar
  156. 156.
    Schölmerich J, Volk BA, Köttgen E et al.: Fibronectin concentration in ascites differentiates between malignant and nonmalignant ascites. Gastroenterology 87: 1160, 1984PubMedGoogle Scholar
  157. 157.
    Schumann GB et al (ed): Clinics in Laboratory Medicine: Symposium on Body Fluid Analysis, pp 193–315; 389–403. Philadelphia: WB Saunders, Co, 1985Google Scholar
  158. 158.
    Scully RE (ed): Case records of the Massachusetts General Hospital: Case 46–1978. N Engl J Med 299:1179, 1978Google Scholar
  159. 159.
    Scully RE (ed): Case records of the Massachusetts General Hospital: Case 22–1985. N Engl J Med 312:1440, 1985Google Scholar
  160. 160.
    Sears D, Hajdu SI: The cytologic diagnosis of malignant neoplasms in pleural and peritoneal effusions. Acta Cytol (Baltimore) 31: 85, 1987Google Scholar
  161. 161.
    Seidel TA, Garbes AD: Cellules grumelees: Old terminology revised: The cytologic diagnosis of chronic lymphocytic leukemia and well-differentiated lymphocytic lymphoma in pleural effusions (Abstract). Acta Cytol 28: 659, 1984Google Scholar
  162. 162.
    Senger DR, Galli SJ, Dvorak AM et al.: Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219: 983, 1983PubMedCrossRefGoogle Scholar
  163. 163.
    Sheid B, Boyce J: Inhibition of lymphocyte mitogenesis by factor(s) released from macrophages isolated from ascitic fluid of advanced ovarian cancer patients. Cancer Immunol Immunother 17: 190, 1984PubMedCrossRefGoogle Scholar
  164. 164.
    Shuman LS, Libshitz HI: Solid pleural manifestations of lymphoma. AJR 142: 269, 1984PubMedGoogle Scholar
  165. 165.
    Siegler R, Koprowska I: Mechanism of ascites tumor formation. Cancer Res 22: 1273, 1962Google Scholar
  166. 166.
    Sigurdsson K, Alm P, Gullberg B: Prognostic factors in malignant epithelial ovarian tumors. Gynecol Oncol 15: 370, 1983PubMedCrossRefGoogle Scholar
  167. 167.
    Silverman PM, Harell GS, Korobkin M: Computed tomography of the abnormal pericardium. AJR 140: 1125, 1983PubMedGoogle Scholar
  168. 168.
    Simel DL, Weinberg JB: Leukemic ascites complicating acute myelomonoblastic leukemia. Arch Pathol Lab Med 109: 365, 1985PubMedGoogle Scholar
  169. 169.
    Skinner DB: Operation for diagnosis and treatment of pericardial effusions. Surgery 96: 738, 1984PubMedGoogle Scholar
  170. 170.
    Smith NJ, Dziura BR, Gondos B: Use of blood group isoantigens in distinguishing benign and malignant cells in effusions (Abstract). Acta Cytol 24: 66, 1980Google Scholar
  171. 171.
    Smith RR, Sternberg SS, Paglia MA, Golbey RB: Fatal pulmonary tumor embolization following peritoneovenous shunting for malignant ascites. J Surg Oncol 16: 27, 1981PubMedCrossRefGoogle Scholar
  172. 172.
    Souter RG, Tarin D, Kettlewell MG: Peritoneovenous shunts in the management of malignant ascites. Br J Surg 70: 478, 1983PubMedCrossRefGoogle Scholar
  173. 173.
    Souter RG, Wells C, Tarin D, Kettlewell MG: Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites. Cancer 55: 1973, 1985PubMedCrossRefGoogle Scholar
  174. 174.
    Spriggs AI, Grunze H: An unusual cytologic presentation of mesothelioma in serous effusions. Acta Cytol 27: 288, 1983PubMedGoogle Scholar
  175. 175.
    Staats BA, Ellefson RD, Budahn LL et al.: The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55: 700, 1980PubMedGoogle Scholar
  176. 176.
    Stang JM, Ruff PD, McEnany MT et al.: Acute massive (pericardial effusive) pulmonary thromboembolism—pulmonary embolectomy revisited. Clin Cardiol 6: 613, 1983PubMedCrossRefGoogle Scholar
  177. 177.
    Stark DD, Higgins CB, Lanzer P et al.: Magnetic resonance imaging of the pericardium: Normal and pathologic findings. Radiology 150: 469, 1984PubMedGoogle Scholar
  178. 178.
    Stehman FB, Ehrlich CE: Peritoneocystic shunt for malignant ascites. Gynecol Oncol 18: 402, 1984PubMedCrossRefGoogle Scholar
  179. 179.
    Szpak CA, Johnston WW, Littich SC et al.: Patterns of reactivity of four novel monoclonal antibodies (B72.3, DF3, B1.1, and B6.2) with cells in human malignant and benign effusion. Acta Cytol 28: 356, 1984PubMedGoogle Scholar
  180. 180.
    Takagi F: Studies on tumor cells in serous effusion. Am J Clin Pathol 24: 663, 1954PubMedGoogle Scholar
  181. 181.
    Taki T, Kojima S, Seto H et al.: Glycolipid composition of acitic fluids from patients with cancer. J Biochem (Tokyo) 96: 1257, 1984Google Scholar
  182. 182.
    Tamura K, Kawano K, Ishizaki J et al.: Ascites with peritoneal myeloid metaplasia in a patient with advanced non-Hodgkin’s lymphoma. Jpn J Clin Oncol 15: 25, 1985PubMedGoogle Scholar
  183. 183.
    Tempero MA, Davis RB, Reed E, Edney J: Thrombocytopenia and laboratory evidence of disseminated intravascular coagulation after shunts for ascites in malignant disease. Cancer 55: 2718, 1985PubMedCrossRefGoogle Scholar
  184. 184.
    To A, Dearnaley DP, Ormerod MG et al.: Epithelial membrane antigen: Its use in the cytodiagnosis of malignancy in serous effusions. Am J Clin Pathol 78: 214, 1982PubMedGoogle Scholar
  185. 185.
    Tötterman KJ, Pesonen E, Siltanen P: Radiation-related chronic heart disease. Chest 83: 875, 1983PubMedCrossRefGoogle Scholar
  186. 186.
    Trigg ME, Swanson JD, Letellier MA: Metastasis of an optic glioma through a ventriculoperitoneal shunt. Cancer 52: 599, 1983PubMedCrossRefGoogle Scholar
  187. 187.
    Turton CW: Pleural effusions. Br J Hosp Med 23: 239, 244; 246, 1980Google Scholar
  188. 188.
    Vellios F, Griffin J: Examination of body fluids for tumor cells. Am J Clin Pathol 24: 676, 1954PubMedGoogle Scholar
  189. 189.
    Vladutiu AO, Adler RH, Brason FW: Diagnostic value of biochemical analysis of pleural effusions: Carcinoembryonic antigen and beta2 microglobulin. Am J Clin Pathol 71: 210, 1979PubMedGoogle Scholar
  190. 190.
    Volpe R, Carbone A: Reed-Sternberg cells in pericardial fluid. Acta Cytol 26: 61, 1982PubMedGoogle Scholar
  191. 191.
    Von Haam E: Cytology of transudates and exudates. Monogr Clin Cytol 5: 1, 1977Google Scholar
  192. 192.
    Von Scheidt W, Kandolf R, Denecke H, Erdmann E: [Primary and secondary chylopericardium] Dtsch Med Wochenschr 111: 1842, 1986CrossRefGoogle Scholar
  193. 193.
    Walts AE, Said JW: Specific tumor markers in diagnostic cytology: Immunoperoxidase studies of carcinoembryonic antigen, lysozyme and other tissue antigens in effusions, washes and aspirates. Acta Cytol 27: 408, 1983PubMedGoogle Scholar
  194. 194.
    Watts KC, Boyo-Ekwueme H, To A, Posnansky M, Coleman DV: Chromosome studies on cells cultured from serous effusions: Use in routine cytologic practice. Acta Cytol 27: 38, 1983PubMedGoogle Scholar
  195. 195.
    Weissberg D, Kaufmann M: Diagnostic and therapeutic pleuroscopy. Experience with 127 patients. Chest 78: 732, 1980PubMedCrossRefGoogle Scholar
  196. 196.
    Weissel M, Punzengruber C, Hartter E et al.: Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin Wochenschr 64: 93, 1986PubMedGoogle Scholar
  197. 197.
    Wied GL, Koss LG, Reagan JW (eds): Compendium on Diagnostic Cytology, 5th ed, pp 465–486. Chicago: The Tutorials of Cytology, 1983Google Scholar
  198. 198.
    Williford ME, Hidalgo H, Putman CE et al.: Computed tomography of pleural disease. AJR 140: 909, 1983PubMedGoogle Scholar
  199. 199.
    Winkelmann M, Pfitzer P: Blind pleural biopsy in combination with cytology of pleural effusions. Acta Cytol 25: 373, 1981PubMedGoogle Scholar
  200. 200.
    Witte CL, Brewer ML, Witte MH, Pond GB: Protean manifestations of pylethrombosis. A review of thirty-four patients. Ann Surg 202: 191, 1985PubMedCrossRefGoogle Scholar
  201. 201.
    Wroblewski F, Wroblewski R: Clinical significance of lactic dehydrogenase activity of serous effusions. Ann Intern Med 48: 813, 1958PubMedGoogle Scholar
  202. 202.
    Wünsch PH, Müller HA: [Cytodiagnosis of malignant non-Hodgkin’s lymphomas in effusions]. Virchows Arch 36: 275, 1981CrossRefGoogle Scholar
  203. 203.
    Yam LT: Granulocytic sarcoma with pleural involvement. Identification of neoplastic cells with cytochemistry. Acta Cytol 29: 63, 1985PubMedGoogle Scholar
  204. 204.
    Yam LT, Jackila AJ: A simple method of preparing smears from bloody effusions for cytodiagnosis. Acta Cytol 27: 114, 1983PubMedGoogle Scholar
  205. 205.
    Yam LT, Winkler CF: Immunochemical diagnosis of oat-cell carcinoma in pleural effusion. Acta Cytol 28: 425, 1984PubMedGoogle Scholar
  206. 206.
    Yamada S, Takeda T, Matsumoto K: Prognostic analysis of malignant pleural and peritoneal effusions. Cancer 51: 136, 1983PubMedCrossRefGoogle Scholar
  207. 207.
    Yoshimura S, Scully RE, Taft PD, Herrington JB: Peritoneal fluid cytology in patients with ovarian cancer. Gynecol Oncol 17: 161, 1984PubMedCrossRefGoogle Scholar
  208. 208.
    Yuasha S, Itoshima T, Nagashima H: Clinical studies of hepatocellular carcinoma with liver cirrhosis and ascites. Acta Med Okayama 38: 291, 1984Google Scholar

Copyright information

© Kluwer Academic Publishers 1989

Authors and Affiliations

  • Rudolf C. Ulirsch
  • Dena M. Gomez

There are no affiliations available

Personalised recommendations